1102682

Michael J. Downing, M.D. — FEI 3014256731

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 22, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Dallas, TX (United States)

Additional Details

Clinical Investigator (CI)